ArticleHealth science reports2020

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial.

Jason Grebely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.